These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 32548120)

  • 81. Expression of α-Synuclein in the mouse retina is confined to inhibitory presynaptic elements.
    Yang Q; Lin X; Xiao J; Zhong W; Wang F; Tan H; Rao B; Qu J; Zhang J
    J Comp Neurol; 2023 Jul; 531(10):1057-1079. PubMed ID: 37002599
    [TBL] [Abstract][Full Text] [Related]  

  • 82. α-synuclein induced synapse damage is enhanced by amyloid-β1-42.
    Bate C; Gentleman S; Williams A
    Mol Neurodegener; 2010 Dec; 5():55. PubMed ID: 21138585
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Differential Membrane Binding and Seeding of Distinct α-Synuclein Fibrillar Polymorphs.
    Shrivastava AN; Bousset L; Renner M; Redeker V; Savistchenko J; Triller A; Melki R
    Biophys J; 2020 Mar; 118(6):1301-1320. PubMed ID: 32059758
    [TBL] [Abstract][Full Text] [Related]  

  • 84. α-Synuclein Impacts on Intrinsic Neuronal Network Activity Through Reduced Levels of Cyclic AMP and Diminished Numbers of Active Presynaptic Terminals.
    Leite K; Garg P; Spitzner FP; Guerin Darvas S; Bähr M; Priesemann V; Kügler S
    Front Mol Neurosci; 2022; 15():868790. PubMed ID: 35721317
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Receptor-Dependent Endocytosis Mediates α-Synuclein Oligomer Transport Into Red Blood Cells.
    Li W; Hu J; Li X; Lu Z; Li X; Wang C; Yu S
    Front Aging Neurosci; 2022; 14():899892. PubMed ID: 35669464
    [TBL] [Abstract][Full Text] [Related]  

  • 86. MAPKAPK2, a potential dynamic network biomarker of α-synuclein prior to its aggregation in PD patients.
    Zhong Z; Li J; Zhong J; Huang Y; Hu J; Zhang P; Zhang B; Jin Y; Luo W; Liu R; Zhang Y; Ling F
    NPJ Parkinsons Dis; 2023 Mar; 9(1):41. PubMed ID: 36927756
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Alpha-Synuclein PET Tracer Development-An Overview about Current Efforts.
    Korat Š; Bidesi NSR; Bonanno F; Di Nanni A; Hoàng ANN; Herfert K; Maurer A; Battisti UM; Bowden GD; Thonon D; Vugts D; Windhorst AD; Herth MM
    Pharmaceuticals (Basel); 2021 Aug; 14(9):. PubMed ID: 34577548
    [TBL] [Abstract][Full Text] [Related]  

  • 88. The regulation of synaptic function by alpha-synuclein.
    Bellani S; Sousa VL; Ronzitti G; Valtorta F; Meldolesi J; Chieregatti E
    Commun Integr Biol; 2010 Mar; 3(2):106-9. PubMed ID: 20585500
    [TBL] [Abstract][Full Text] [Related]  

  • 89. The Membrane Interaction of Alpha-Synuclein.
    Liu C; Zhao Y; Xi H; Jiang J; Yu Y; Dong W
    Front Cell Neurosci; 2021; 15():633727. PubMed ID: 33746714
    [TBL] [Abstract][Full Text] [Related]  

  • 90. α-Synuclein in the Synaptic Vesicle Liquid Phase: Active Player or Passive Bystander?
    Brodin L; Milovanovic D; Rizzoli SO; Shupliakov O
    Front Mol Biosci; 2022; 9():891508. PubMed ID: 35664678
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Synaptic vesicle-inspired nanoparticles with spatiotemporally controlled release ability as a "nanoguard" for synergistic treatment of synucleinopathies.
    Ji W; Li Y; Liu R; Lu Z; Liu L; Shi Z; Shen J; Zhang X
    Mater Horiz; 2021 Apr; 8(4):1199-1206. PubMed ID: 34821912
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Parkinsonism mutations in DNAJC6 cause lipid defects and neurodegeneration that are rescued by Synj1.
    Jacquemyn J; Kuenen S; Swerts J; Pavie B; Vijayan V; Kilic A; Chabot D; Wang YC; Schoovaerts N; Corthout N; Verstreken P
    NPJ Parkinsons Dis; 2023 Feb; 9(1):19. PubMed ID: 36739293
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Expression of ERα, its ERαΔ3 Splice Variant and γ-SYNUCLEIN in Ovarian Cancer: A Pilot Study.
    Cheung KT; Taylor SE; Patel II; Bentley AJ; Stringfellow HF; Fullwood NJ; Martin-Hirsch PL; Martin FL
    Br J Med Med Res; 2011 Oct; 1(4):430-444. PubMed ID: 22076318
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Corrigendum: Structural basis of synaptic vesicle assembly promoted by α-synuclein.
    Fusco G; Pape T; Stephens AD; Mahou P; Costa AR; Kaminski CF; Schierle GSK; Vendruscolo M; Veglia G; Dobson CM; De Simone A
    Nat Commun; 2017 May; 8():15667. PubMed ID: 28492274
    [No Abstract]   [Full Text] [Related]  

  • 95. Correction: Boiten et al. Pathologically Decreased CSF Levels of Synaptic Marker NPTX2 in DLB Are Correlated with Levels of Alpha-Synuclein and VGF.
    Boiten WA; van Steenoven I; Xiao MF; Worley PF; Noli B; Cocco C; Ferri GL; Lemstra AW; Teunissen CE
    Cells; 2022 Feb; 11(4):. PubMed ID: 35203406
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Retraction Note to: Differential regulation of wild-type and mutant alpha-synuclein binding to synaptic membranes by cytosolic factors.
    Wislet-Gendebien S; Visanji NP; Whitehead SN; Marsilio D; Hou W; Figeys D; Fraser PE; Bennett SAL; Tandon A
    BMC Neurosci; 2021 Jun; 22(1):40. PubMed ID: 34082697
    [No Abstract]   [Full Text] [Related]  

  • 97. Withdrawal: Effect of Ser-129 phosphorylation on interaction of α-synuclein with synaptic and cellular membranes.
    Visanji NP; Wislet-Gendebien S; Oschipok LW; Zhang G; Aubert I; Fraser PE; Tandon A
    J Biol Chem; 2020 Sep; 295(39):13695. PubMed ID: 32978333
    [No Abstract]   [Full Text] [Related]  

  • 98. Effects of Excess Brain-Derived Human α-Synuclein on Synaptic Vesicle Trafficking.
    Román-Vendrell C; Medeiros AT; Sanderson JB; Jiang H; Bartels T; Morgan JR
    Front Neurosci; 2021; 15():639414. PubMed ID: 33613189
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Alpha-Synuclein: Mechanisms of Release and Pathology Progression in Synucleinopathies.
    Brás IC; Outeiro TF
    Cells; 2021 Feb; 10(2):. PubMed ID: 33673034
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Excess phosphoserine-129 α-synuclein induces synaptic vesicle trafficking and declustering defects at a vertebrate synapse.
    Wallace JN; Crockford ZC; Román-Vendrell C; Brady EB; Hoffmann C; Vargas KJ; Potcoava M; Wegman ME; Alford ST; Milovanovic D; Morgan JR
    Mol Biol Cell; 2024 Jan; 35(1):ar10. PubMed ID: 37991902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.